Skip to main navigation Skip to search Skip to main content

Fully Covered Self-Expanding Metal Stent vs Multiple Plastic Stents to Treat Benign Biliary Strictures Secondary to Chronic Pancreatitis: A Multicenter Randomized Trial

  • Mohan Ramchandani
  • , Sundeep Lakhtakia
  • , Guido Costamagna
  • , Andrea Tringali
  • , Andreas Püspöek
  • , Barbara Tribl
  • , Werner Dolak
  • , Jacques Devière
  • , Marianna Arvanitakis
  • , Schalk van der Merwe
  • , Wim Laleman
  • , Thierry Ponchon
  • , Vincent Lepilliez
  • , Armando Gabbrielli
  • , Laura Bernardoni
  • , Marco J. Bruno
  • , Jan Werner Poley
  • , Urban Arnelo
  • , James Lau
  • , André Roy
  • Michael Bourke, Arthur Kaffes, Horst Neuhaus, Joyce Peetermans, Matthew Rousseau, D. Nageshwar Reddy*
*Corresponding author for this work
  • Asian Institute of Gastroenterology India
  • Agostino Gemelli University Hospital Foundation IRCCS
  • Catholic University of the Sacred Heart
  • St. John′s Hospital
  • Medical University of Vienna
  • Hôpital Erasme
  • University Hospitals Leuven
  • Hôpital Édouard Herriot
  • University of Verona
  • Karolinska University Hospital
  • Prince of Wales Hospital Hong Kong
  • Centre Hospitalier de l'Université de Montréal
  • The University of Sydney
  • Royal Prince Alfred Hospital
  • Evangelisches Krankenhaus Düsseldorf
  • Boston Scientific Corporation

Research output: Contribution to journal › Article › Academic › peer-review

72 Citations (Scopus)

Abstract

BACKGROUND & AIMS: Benign biliary strictures (BBS) are complications of chronic pancreatitis (CP). Endotherapy using multiple plastic stents (MPS) or a fully covered self-expanding metal stent (FCSEMS) are acceptable treatment options for biliary obstructive symptoms in these patients.

METHODS: Patients with symptomatic CP-associated BBS enrolled in a multicenter randomized noninferiority trial comparing 12-month treatment with MPS vs FCSEMS. Primary outcome was stricture resolution status at 24 months, defined as absence of restenting and 24-month serum alkaline phosphatase not exceeding twice the level at stenting completion. Secondary outcomes included crossover rate, numbers of endoscopic retrograde cholangiopancreatography (ERCPs) and stents, and stent- or procedure-related serious adverse events.

RESULTS: Eighty-four patients were randomized to MPS and 80 to FCSEMS. Baseline technical success was 97.6% for MPS and 98.6% for FCSEMS. Eleven patients crossed over from MPS to FCSEMS, and 10 from FCSEMS to MPS. For MPS vs FCSEMS, respectively, stricture resolution status at 24 months was 77.1% (54/70) vs 75.8% (47/62) (P = .008 for noninferiority intention-to-treat analysis), mean number of ERCPs was 3.9 ± 1.3 vs 2.6 ± 1.3 (P < .001, intention-to-treat), and mean number of stents placed was 7.0 ± 4.4 vs 1.3 ± .6 (P < .001, as-treated). Serious adverse events occurred in 16 (19.0%) MPS and 19 (23.8%) FCSEMS patients (P = .568), including cholangitis/fever/jaundice (9 vs 7 patients respectively), abdominal pain (5 vs 5), cholecystitis (1 vs 3) and post-ERCP pancreatitis (0 vs 2). No stent- or procedure-related deaths occurred.

CONCLUSIONS: Endotherapy of CP-associated BBS has similar efficacy and safety for 12-month treatment using MPS compared with a single FCSEMS, with FCSEMS requiring fewer ERCPs over 2 years. (ClinicalTrials.gov, Number: NCT01543256.).

Original languageEnglish
Pages (from-to)185-195
Number of pages11
JournalGastroenterology
Volume161
Issue number1
DOIs
Publication statusPublished - 1 Jul 2021

Bibliographical note

Copyright © 2021. Published by Elsevier Inc.

Fingerprint

Dive into the research topics of 'Fully Covered Self-Expanding Metal Stent vs Multiple Plastic Stents to Treat Benign Biliary Strictures Secondary to Chronic Pancreatitis: A Multicenter Randomized Trial'. Together they form a unique fingerprint.

Cite this